Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04329637
Other study ID # PRO00027409
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 5, 2016
Est. completion date December 15, 2019

Study information

Verified date March 2020
Source Medical College of Wisconsin
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cyclic vomiting syndrome is a chronic functional gastrointestinal disorder that is a significant health care problem. It affects 1-2% of the population and imposes an enormous burden on patients, families and the health care system. Due to the recalcitrant nature of the disease, patients have high rates of health care utilization with multiple emergency department visits and hospitalizations. These in turn lead to school and work absenteeism, job loss, divorce and even disability. CVS is also associated with multiple comorbid conditions such as anxiety and depression, which further contribute to disease severity. Both neuroimaging studies and other data demonstrate the role of the central nervous system in the pathophysiology of CVS with stress being a significant trigger for episodes of CVS. In summary, CVS is common, disabling and expensive and is associated with significant psychosocial comorbidity that contributes to impaired quality of life . Our current healthcare delivery model is disease-centric and does not adequately address the psychosocial barriers that contribute to poor health in this patient population. We propose a novel, collaborative, integrative health care model that shifts the paradigm of care from one that is episodic and disease-centered to a patient-centered approach that addresses psychosocial determinants of health not addressed in our current traditional health care system. We will incorporate meditation practices that have been shown to reduce psychological distress and also add a care coordinator to our health care delivery team. The primary role of the care coordinator is to identify patient goals, preferences and barriers to self-management and address psychosocial and environmental issues that determine health. Patients will be randomized to either the integrative health care model or usual care. The primary aim of our study is to determine the impact of our proposed integrative health care model on health care outcomes which will include a reduction in psychological distress, improvement in coping skills for managing chronic disease, cognitive symptom management, improvement in health-related quality of life and reduction in health care utilization. This collaborative effort between physicians, community partners, and allied health personnel will redesign the health care delivery system, facilitate access to appropriate healthcare services, optimize chronic disease management and improve overall healthcare outcomes.


Description:

Background & Aims: Cyclic vomiting syndrome (CVS) is associated with psychosocial comorbidity and often triggered by stress. The current disease-centered model of care does not address psychosocial factors that impact patient outcomes. The investigators hypothesized that a holistic, patient-centered care model integrating meditation and addressing psychosocial needs through a care coordinator, will improve healthcare outcomes in CVS.

Methods: The investigators conducted a prospective randomized controlled trial of 49 patients with CVS (mean age: 34 ± 14 years; 81% female) who were randomized to conventional healthcare (control group) or Integrative Health Care (IHC) (27: control group, 22: IHC group;). In the IHC group, patients were assigned a care coordinator and received meditation sessions from certified trainers from the Heartfulness Institute. Outcomes including psychological distress, coping strategies to manage chronic stress, cognitive symptom management, and Health-Related Quality of Life were measured with validated tools. An intention-to-treat analysis was performed.


Recruitment information / eligibility

Status Completed
Enrollment 74
Est. completion date December 15, 2019
Est. primary completion date February 5, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- All subjects with CVS

Exclusion Criteria:

- Severe cognitive impairment, active mental health problems such as suicidal ideation, severe anxiety or depression requiring inpatient care, or an inability to sit for at least 20 minutes. Subjects with severe cardiopulmonary diseases, malignancy, liver cirrhosis, renal failure on dialysis or those who were pregnant at the time of enrollment were excluded.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Integrative healt care
Meditation and use of a care cordinator

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Medical College of Wisconsin

Outcome

Type Measure Description Time frame Safety issue
Primary Levels of psychological distress is measured using a validated questionnaire called the Basic Symptom Inventory Basic symptom inventory The Brief Symptom Inventory (BSI) consists of 53 items covering nine symptom dimensions: Somatization, Obsession-Compulsion, Interpersonal Sensitivity, Depression, Anxiety, Hostility, Phobic anxiety, Paranoid ideation and Psychoticism; and three global indices of distress: Global Severity Index, Positive Symptom Distress Index, and Positive Symptom Total. The global indices measure current or past level of symptomatology, intensity of symptoms, and number of reported symptoms, respectively. 6 months
Secondary Mutiple domains of coping will be measured by the COPE questionanire which is a validated tool COPE questionanire: The COPE questionnaire consists of the following. Five scales (of four items each) measure conceptually distinct aspects of problem-focused coping (active coping, planning, suppression of competing activities, restraint coping, seeking of instrumental social support); five scales measure aspects of what might be viewed as emotional-focused coping (seeking of emotional social support, positive reinterpretation, acceptance, denial, turning to religion); and three scales measure coping responses that arguably are less useful (focus on and venting of emotions, behavioral disengagement, mental disengagement). 6 months
See also
  Status Clinical Trial Phase
Withdrawn NCT00728104 - The Use of L-Carnitine And CoQ10 Supplements In the Treatment of Cyclic Vomiting Syndrome (CVS) N/A
Recruiting NCT05256160 - Cortical Excitability in Cyclic Vomiting Syndrome N/A
Recruiting NCT05961995 - Heartfulness Meditation Cyclic Vomiting Syndrome N/A
Completed NCT03434652 - Auricular Neurostimulation for Cyclic Vomiting Syndrome N/A
Completed NCT04645953 - Staccato Granisetron® (AZ 010) for the Treatment of Cyclic Vomiting Syndrome Phase 2
Completed NCT03470181 - Applying Nutrient Drink Test in Understanding Pathophysiology of CVS
Completed NCT03295760 - Analysis of Q10 Coenzyme Efficacy for Long-term Treatment of Cyclic Vomiting Syndrome in Children N/A
Terminated NCT05065567 - Haloperidol, Droperidol, Ondansetron in Cannabis Hyperemesis Phase 2
Terminated NCT04721171 - Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome. N/A